Zibb.com: AaiPharma, Inc. (Industry News & Blogs)

BUYINS.NET: AMT,VTR, HNZ, EIX, RL, MRX Expected To Be Higher Lead...

Wed, 28 Oct 2009 05:07:32 GMT

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and October/November earnings reports. American Tower Corp (NYSE: AMT), Ventas

AAIPharma Services Begins Anew as a Standalone Company

Tue, 01 Sep 2009 04:00:00 GMT

L. Lee Karras, CEO of AAIPharma Services, outlines the companys growth strategy in contract pharmaceutical development and manufacturing.

AAIPharma, Inc. Executives Work to Buy Shawnee Business

Mon, 24 Aug 2009 12:00:00 GMT

Bizjournals.com -- Top executives at a Shawnee pharmaceutical testing laboratory are bidding to buy the business. Four senior managers with AAIPharma Inc.

AAIPharma executives work to buy Shawnee business

Mon, 24 Aug 2009 04:00:00 GMT

Darioush Dadgar, vice president of bioanalytical operations at AAIPharma Inc., is one of four executives who is trying to buy the testing laboratory. “We really think we can succeed a lot better once we are a separate entity,” he says.

Executive Moves: AAIPharma Services

Wed, 19 Aug 2009 14:38:00 GMT

Christopher Smith, CQE, RAC has been appointed to vice president of quality and regulatory affairs at AAIPharma Services Corp.

Water Street Healthcare Partners Acquires Pharmaceutical Developm...

Mon, 03 Aug 2009 13:15:20 GMT

Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory

Water Street Healthcare Partners Acquires Pharma Unit

Thu, 16 Jul 2009 20:02:00 GMT

Private equity firm focused on the health care industry said it acquired the Pharmaceutical Development division from AAIPharma Inc.

Water Street Healthcare Partners Acquires Pharmaceutical Developm...

Thu, 16 Jul 2009 00:00:00 GMT

Venture capital news. Updated daily. VC deal news, fund news, transition news, industry news.

Emisphere Technologies and AAIPharma to Expand Use of Eligen Tech...

Fri, 12 Jun 2009 04:00:00 GMT

Emisphere Technologies, Inc. (Cedar Knolls, NJ), a biopharmaceutical company that focuses on delivery of therapeutic molecules using its Eligen Technology, and AAIPharma, Inc. (Wilmington, NC), have formed a strategic alliance intended to expand the application of Emisphere' s Eligen Technology and

Emisphere's SNAC Carrier Achieves Provisional GRAS Status for Use...

Fri, 01 May 2009 12:30:00 GMT

CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--Emisphere Technologies, Inc. (NASDAQ: EMIS - News) today announced that the company has been informed

SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivot...

Thu, 06 Nov 2008 14:00:00 GMT

SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen. - Pivotal Phase III Trial Primary Endpoints Achieved for SCOLR's 12 Hour Ibuprofen

May 13, 2008, issue

Tue, 13 May 2008 20:10:05 GMT

The Commission today announced a final resolution of the Commission's civil action against David M. Hurley (Hurley), former chief operating officer of aaiPharma, Inc. (aaiPharma). Pursuant to a final judgment entered by the Court on May 5, 2008, Hurley was ordered to pay a civil penalty of $50,000.

Phase Forward lands N.C.-based CRO as client

Wed, 29 Aug 2007 14:44:49 GMT

Waltham-based Phase Forward Inc. reports that a global contract research firm based in North Carolina will use its information technology designed for clinical trials. AAIPharma Inc., of Wilmington, N.C.

Jobs and People-06/12/2004-CMR

Fri, 03 Dec 2004 18:52:38 GMT

Robert E. Campbell has been appointed lead director of Barrier Therapeutics Inc.’s board of directors. He will chair the meetings of the independent directors in executive sessions of the board and facilitate communications between the members of the board and the chairman of the board. Mr.

AAIPharma Receives GMP Certification From Sweden's Medical Produc...

AAIPharma has received its second certification from a European Union (EU) regulatory body that the company’s operations are in compliance with EU Good Manufacturing Practice (GMP) regulations. Following an audit of AAIPharma’s manufacturing, testing and stability operations located in Wilmington,

Products and Exchanges -

Búsqueda Contratos | Mapa Seleccione Negociar o Servicios Cuenta Trader Workstation WebTrader Menu Gestion Cuenta Terminar Aplicacion Extractos Formularios Fiscales Depositos y Transferencias Retiradas Estado de Fondos Abrir una Cuenta Solicitud de Cuenta e Información Close Window Individuales

Bankruptcy Litigation Blog: Movin' on Up, Finally! -- Long Overdu...

The Office of the Third Circuit Executive is now taking comments on the qualifications of these designates through December 1st, and decide soon thereafter. For those who know the candidates personally, I hope that you take the time to send in your comments.

Martindale.com - Legal Article: Sanctions for Improper Privilege ...

Sanctions for Improper Privilege Assertions and Privilege Log Revisions: Law article by David M. Greenwald;

In AAIpharma, Inc. v. Kremers Urban Dev. Co., No. 02 Civ. 9628 (BSJ) (RLE), 2006 WL 3096026 (S.D.N.Y. Oct. 31, 2006), the court imposed sanctions on plaintiff for improperly

R&D Directions

A new executive takes on the challenges facing aaiPharma Inc. Ludo Reynders, Ph.D., became president and CEO, replacing Fred Sancilio, Ph.D. With the arrival of Dr. Reynders, Dr.

Wall Street: Stocks slide amid investor nervousness

NEW YORK Investors left stocks in limbo Monday, making few moves while they awaited Federal Reserve Chairman Alan Greenspan's testimony before Congress later this week. The major indexes ended narrowly lower after seesawing through the session, but more stocks gained than declined.

Star-News (Wilmington, NC) back issues | Archives from 200609 | H...

HighBeam Research - Newspaper archives and journal articles Log in | Free trial | What's in a free trial | Help Research articles and archives from 3,500+ publications Advanced search|Categories Top publication categories at HighBeam Research Hide hide Newspapers International Newspapers, Local

AtheroGenics Announces Key Senior Additions to Clinical and Busin...

ATLANTA, May 12 /PRNewswire-FirstCall/ -- AtheroGenics, Inc. (Nasdaq: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced the appointment of Philip J. Krape as Senior Director, Business Development, and Robert D. Small, Ph.D.

Medical Device Business Week (2004-03-31) | NewsRx

- Promotion, appointment of regulatory affairs post reported at drug firm Aphton Corporation - Biotech company announces exercise of underwriters' over-allotment option Atrix Laboratories, Inc. - Drug delivery company reports improved financial results AutoImmune, Inc.

PharmiWeb: The Heart of Life Sciences on the Web

Offshoring of clinical trials is increasing as companies in the U.S. are finding challenges in clinical trial research ranging from cost, patient recruitment, patient compliance during participation, qualified professionals, new clinical trial patients, and other problems.

Page Not Found - 404

If you received this error after clicking a link within the AAIPharma web site, please use the contact form to let us know where the broken link is located. We will correct it as soon as possible.